- Home
- JAGX vs ELAB Comparison
JAGX vs ELAB Comparison
Compare JAGX & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- ELAB
- Stock Information
- Founded
- JAGX 2013
- ELAB 2020
- Country
- JAGX United States
- ELAB United States
- Employees
- JAGX N/A
- ELAB N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- ELAB
- Sector
- JAGX Health Care
- ELAB
- Exchange
- JAGX Nasdaq
- ELAB Nasdaq
- Market Cap
- JAGX 3.5M
- ELAB 3.2M
- IPO Year
- JAGX N/A
- ELAB 2023
- Fundamental
- Price
- JAGX $2.39
- ELAB $2.57
- Analyst Decision
- JAGX Strong Buy
- ELAB
- Analyst Count
- JAGX 1
- ELAB 0
- Target Price
- JAGX $60.00
- ELAB N/A
- AVG Volume (30 Days)
- JAGX 98.7K
- ELAB 204.1K
- Earning Date
- JAGX 08-12-2025
- ELAB 08-13-2025
- Dividend Yield
- JAGX N/A
- ELAB N/A
- EPS Growth
- JAGX N/A
- ELAB N/A
- EPS
- JAGX N/A
- ELAB N/A
- Revenue
- JAGX $11,552,000.00
- ELAB N/A
- Revenue This Year
- JAGX $22.41
- ELAB N/A
- Revenue Next Year
- JAGX $30.00
- ELAB N/A
- P/E Ratio
- JAGX N/A
- ELAB N/A
- Revenue Growth
- JAGX 13.93
- ELAB N/A
- 52 Week Low
- JAGX $2.28
- ELAB $1.95
- 52 Week High
- JAGX $110.75
- ELAB $756.00
- Technical
- Relative Strength Index (RSI)
- JAGX 29.08
- ELAB 62.59
- Support Level
- JAGX $2.53
- ELAB $2.18
- Resistance Level
- JAGX $2.79
- ELAB $2.46
- Average True Range (ATR)
- JAGX 0.20
- ELAB 0.18
- MACD
- JAGX 0.12
- ELAB 0.04
- Stochastic Oscillator
- JAGX 8.96
- ELAB 61.90
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.